TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
1.410
-0.210 (-12.96%)
At close: Apr 2, 2026, 4:00 PM EDT
1.460
+0.050 (3.52%)
After-hours: Apr 2, 2026, 7:26 PM EDT

TuHURA Biosciences Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2024FY 2024FY 2023
Period Ending
Dec '25 Dec '24 Jun '24 Dec '23 Jun '23
Net Income
-30.05-21.68-8.32-29.32-14.65
Depreciation & Amortization
0.070.120.060.183.29
Stock-Based Compensation
6.421.960.610.481.49
Other Adjustments
-0.921.590.1916.220.2
Changes in Accounts Payable
-3.763.64-0.580.34-0.44
Changes in Other Operating Activities
0.61-0.360.870.15-1.75
Operating Cash Flow
-27.63-14.73-7.18-11.95-11.87
Capital Expenditures
-0.08-0.06-0.02-0.08-0.23
Payments for Business Acquisitions
----1.22-
Investing Cash Flow
-1.34-6.05-0.02-1.3-0.23
Long-Term Debt Issued
328.57-2.69-
Long-Term Debt Repaid
-2.33----
Net Long-Term Debt Issued (Repaid)
0.6728.57-2.69-
Issuance of Common Stock
21.927.0510.58-1.9
Repurchase of Common Stock
----0.02-
Net Common Stock Issued (Repurchased)
21.927.0510.58-0.021.9
Preferred Share Dividends Paid
-0.01--0.01--0.01
Other Financing Activities
-2.66-5.84---0.04
Financing Cash Flow
19.9329.7710.572.661.85
Net Cash Flow
-9.048.993.37-10.59-10.25
Free Cash Flow
-27.71-14.79-7.2-12.03-12.1
Free Cash Flow Per Share
-0.58-0.79-9.56-15.98-261.35
Levered Free Cash Flow
-32.549.26-8.18-26.05-14.16
Unlevered Free Cash Flow
-34.95-14.30.33-29.180.86
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q